We look forward to meeting you
on 23-25 October 2024.
Dear Colleagues, Dear Friends,
On behalf of the Masaryk Memorial Cancer Institute and the Organizing Committee, we are honored to invite you to participate in the 48th Brno Oncology Days (BOD) and the 38th Nursing Conference. Taking place on October 23-25, 2024, at the Congress Center in Hall “E” within the Brno Exhibition Center grounds, this prestigious conference, with its unique history, is the largest oncology meeting in the Czech Republic.
Last year, our BOD welcomed over 2,200 participants and featured nearly 350 presentations. This year, we eagerly anticipate your participation and look forward to meeting you again. The conference is open to professionals across various fields, including gynecology, urology, surgery, dermatology, and pharmacy.
You can view this year's program here.
We also cordially invite you to the international section, IBOD, which will feature numerous esteemed foreign experts this year. Alongside Breaking News, the IBOD topics will include Genitourinary Tumors, Head and Neck Tumors, Sarcomas, and many others. Don’t miss this unique opportunity to engage with leading experts from around the world.
Registration for passive participation (until October 15) is currently open. For updates, please follow our website.
Don't miss our significant oncology event of the year!
Save the date!
BOD 2025: 22–24 October
BOD 2026: 21–23 October
Networking Brings Professionals Together
Join us in Brno and network with your colleagues, interact with key opinion leaders, ask questions, and debate burning topics in the field of medical oncology in a uniquely meaningful way.
Brno Oncology Days
Brno Oncology Days (BOD) is known for convening oncology experts in a friendly setting for three days of inspiring, innovative discussion on the most relevant challenges in oncology and for multidisciplinary meetings, treatment standards/guidelines, educational and scientific sessions. The conference objectives are designed to introduce the audience to the standard of care but also the latest information on modern therapies and emerging treatments in early development.
